One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
- :
Price : 100$- Special Price : 50$
Celebrating the life and scientific contributions of Barry Brenner in nephrology Free
doi : 10.1093/ndt/gfae206
Volume 40, Issue 3, March 2025
Does amino acid infusion improve kidney outcomes in patients at high risk for postsurgical AKI?
doi : 10.1093/ndt/gfae183
Women of European Renal Association (WERA) task force: together for more awareness towards gender balance in nephrology
doi : 10.1093/ndt/gfae190
Biology of calcium homeostasis regulation in intestine and kidney Open Access
doi : 10.1093/ndt/gfae204
Ethical considerations on the use of big data and artificial intelligence in kidney research from the ERA ethics committee Open Access
doi : 10.1093/ndt/gfae267
Prophylactic treatment of FSGS recurrence in patients who relapsed on a previous kidney graft Open Access
doi : 10.1093/ndt/gfae108
Trends and socioeconomic inequality of the burden of congenital abnormalities of the kidney and urinary tract among children and adolescents Free
doi : 10.1093/ndt/gfae115
Kidney outcomes with SGLT2 inhibitor versus DPP4 inhibitor use in older adults with diabetes Open Access
doi : 10.1093/ndt/gfae158
Diabetic status and the performances of creatinine- and cystatin C–based eGFR equations
doi : 10.1093/ndt/gfae161
A novel real-time model for predicting acute kidney injury in critically ill patients within 12 hours
doi : 10.1093/ndt/gfae168
A randomized crossover trial of regional anticoagulation modalities for intermittent haemodialysis
doi : 10.1093/ndt/gfae155
Prognostic impact of post-transplant diabetes mellitus in kidney allograft recipients: a meta-analysis Open Access
doi : 10.1093/ndt/gfae185
Antibody-mediated rejection diagnosed in early protocol biopsies in high immunological risk kidney transplant recipients
doi : 10.1093/ndt/gfae186
Remote monitoring of automated peritoneal dialysis reduces mortality, adverse events and hospitalizations: a cluster-randomized controlled trial Open Access
doi : 10.1093/ndt/gfae188
Prospective validation of initial eculizumab dosing in adults with atypical hemolytic uremic syndrome Open Access
doi : 10.1093/ndt/gfae244
Biomarker-guided infliximab therapy for immune checkpoint inhibitor-induced acute interstitial nephritis
doi : 10.1093/ndt/gfae257
Correction to: CKD therapy to improve outcomes of immune-mediated glomerular diseases Free
doi : 10.1093/ndt/gfae072
Correction to: Associations of neutral pH, low-GDP peritoneal dialysis solutions with patient survival, transfer to haemodialysis and peritonitis Open Access
doi : 10.1093/ndt/gfae073
